homeostasis/metabolism
N |
• serum glucagon and adrenaline levels
• no obvious phenotype regarding weight gain, food intake, water intake, oxygen consumption, carbon dioxide emission or respiratory exchange ratio (RER)
|
hypoglycemia
(
J:256580
)
• significantly lower fasting blood glucose level
|
• after oral or intraperitoneal injection of glucose
|
• reduced catecholamine content in adrenal chromaffin cells
|
• after oral or intraperitoneal injection of glucose
|
• according to insulin tolerance test
|
endocrine/exocrine glands
• absent vesicular ATP transport in adrenal chromaffin cells
• reduced catecholamine content in adrenal chromaffin cells
|
• reduced catecholamine content in adrenal chromaffin cells
• absent vesicular ATP transport in adrenal chromaffin cells
|
nervous system
• reduced catecholamine content in adrenal chromaffin cells
• absent vesicular ATP transport in adrenal chromaffin cells
|
behavior/neurological
N |
• no obvious phenotype regarding locomotor activity, and open field and plus maze behaviors
|
growth/size/body
N |
• no obvious phenotype regarding weight gain, body size, morphology, food intake or water intake
|
respiratory system
N |
• no obvious phenotype regarding oxygen consumption, carbon dioxide emission or respiratory exchange ratio (RER)
|